Nuffield Division of Clinical Laboratory Sciences
Head of Division
About NDCLS
Our aim is to study the pathology of human disease from the molecular to systems level, and to translate our findings into treatments for human disorders.
Read moreLatest publications
-
Platelet transfusion in neonatal intensive care units of 22 European countries: a prospective observational study
Journal article
Houben NAM. et al, (2024), The Lancet Regional Health - Europe, 47
-
Editorial: Advances in craniosynostosis-Basic science to clinical practice.
Journal article
Moazen M. and Twigg SRF., (2024), J Anat, 245, 813 - 814
-
INCA033989: the first shot on goal for MPNs?
Journal article
Benlabiod C. and Psaila B., (2024), Blood, 144, 2278 - 2279
-
Onwards! Open science and the (PLOS) genetics community
Journal article
Dudley AM. et al, (2024), PLOS Genetics, 20, e1011466 - e1011466
The Latest News
Transformative treatments for children with fatal genetic lung diseases
15 November 2024
AlveoGene, a company co-founded by two of our scientists, today moves closer to approval of its novel inhaled gene therapy for a rare deficiency which causes fatal respiratory distress syndrome in newborns.
Grant awarded to develop artificial intelligence tools to understand the bone marrow landscape
14 August 2024
Our researchers have received $200,000 to develop artificial intelligence tools to better diagnose what goes wrong in the bone marrow of myeloproliferative neoplasm (MPN) patients.
Experts outline priority areas which should be addressed to advance treatment for inherited lung diseases
29 July 2024
An expert group including Deborah Gill, Professor of Gene Medicine in RDM’s Nuffield Division of Clinical Laboratory Sciences, has published a new position paper which addresses the gaps in research and treatment development for familial pulmonary fibrosis (FPF) – a collection of individually rare and severe genetically inherited lung diseases.